News and analysis on global M&A and corporate financing strategies

Finance / Argentina

Recalcine Forms Laboratorio Internacional Argentino

July 2011 | M&A Analysis

Santiago-based Recalcine (Corporación Farmacéutica Recalcine, CFR) has merged its two Argentine operations, Fada Pharma and Northia, to form Laboratorio Internacional Argentino.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Weekly Articles
Carrefour Linked To Argentine Buy

Finance / Argentina Reports in the Argentine press suggest that French retail giant Carrefour is in talks to buy domestic supermarket chain Eki, which is going through bankruptcy proceedings. Eki owns around 129 stores and...
May 2012
YPF Nationalisation Dashes Shale Hopes

Finance / Argentina CFW View: The nationalisation of YPF, which has long been anticipated by CFW, is a very negative development for Argentina's oil and gas industry. The country will now struggle to raise the substantial...
April 2012
Quite The Luxury: First Retail Sector ECM Deal Of 2012

Finance Last week the key story in the luxury goods sector played out far away from the catwalk. On February 6, French luxury goods retailer LVMH Group ( Moët Hennessy Louis Vuitton ) completed a US$737mn follow-on...
February 2012
Andina/ Polar Merger Could Be Prelude To Even Bigger Deals

Finance / Argentina Chilean Coca-Cola bottlers Embotelladora Andina and Embotelladoras Coca-Cola Polar have signed a preliminary agreement to merge their operations. The all-share deal would see Andina take an 80% stake in...
February 2012
Rebalancing Of The Power In Latin American ECM Activity

Finance / Argentina The times they are a-changin' in South America. With the volume of equity capital market (ECM) issuers from regional heavyweight Brazil in decline, the stage has been set for others nations to take up...
January 2012


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2012 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS